Drugs & Targets FDA grants Priority Review for BMS agent lisocabtagene maraleucel February 14, 2020Vol.46 No.07
Drugs & Targets FDA grants Priority Review for Seattle Genetics agent tucatinib February 14, 2020Vol.46 No.07
Drugs & Targets FDA grants Nanobiotix Fast Track designation for investigation of NBTXR3 in head and neck February 14, 2020Vol.46 No.07
Drugs & Targets Myriad submits sPMA for myChoice CDx with Lynparza in first-line maintenance therapy in advanced ovarian cancer February 14, 2020Vol.46 No.07
Clinical Roundup City of Hope Triplex vaccine reduces rate of CMV complications in transplant recipients by half February 14, 2020Vol.46 No.07
Clinical Roundup Study: Radiation therapy for soft tissue sarcoma can be cut from five weeks to five days February 14, 2020Vol.46 No.07
Clinical Roundup Xtandi demonstrates significant improvement in OS in nmCRPC February 14, 2020Vol.46 No.07
Clinical Roundup Vape users show chemical changes in their genome linked to cancer February 14, 2020Vol.46 No.07
